drugset / Trial / NCT04395417

Injection Therapy in Patients With Lateral Epicondylitis

NCT04395417

Completed 32 enrolled Hacettepe University
RandomizedParallel-groupSingle-blindTreatment

Summary

Lateral epicondylitis is a painful enthesopathy of the common extensor tendon at the lateral part of the elbow, with a prevalence of 1-3 % in the general population. In the treatment of lateral epicondylitis, the role of biological-based therapies has begun to investigate regeneration and optimize tendon healing. Prolotherapy (PrT) and hyaluronic acid (HA) injections are biological based treatments. Previous studies have shown benefit of PrT in the treatment of tendinopathies. Preliminary findings demonstrated that HA could be clinically effective in the treatment of enthesopathies. Considering the paucity of HA studies (which also lack a control group) and the proposed mechanism of action of both PrT and HA is through cell proliferation and the healing process of tendons, this study was conducted to compare the effect of PrT and HA in chronic lateral epicondylitis .

Timeline

Start
2018-05-02
Primary completion
2018-09-15
Completion
2018-09-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dextrose Unknown 15 % Other
Subject Hyaluronic Acid Other / unclassified 30 mg Other
Comparator Lidocaine Other / unclassified 2 % Other

Indications